Improving the solubility and in vitro cytotoxicity (anticancer activity) of ferulic acid by loading it into cyclodextrin nanosponges

References

• Assadpour E, Jafari SM, Esfanjani AF. Protection of phenolic compounds within nanocarriers. CAB Rev. 2017;12(057):1–8. doi:10.1079/PAVSNNR201712057
   Google Scholar
• Nankar R, Prabhakar PK, Doble M. Hybrid drug combination: combination of ferulic acid and metformin as anti-diabetic therapy. Phytomedicine. 2017;37:10–13. doi:10.1016/j.phymed.2017.10.01529126698
   PubMed Web of Science ®Google Scholar
• Zhao Z, Moghadasian MH. Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: a review. Food Chem. 2008;109(4):691–702. doi:10.1016/j.foodchem.2008.02.03926049981
   PubMed Web of Science ®Google Scholar
• Yang GW, Jiang JS, Lu WQ. Ferulic acid exerts anti-angiogenic and anti-tumor activity by targeting fibroblast growth factor receptor 1-mediated angiogenesis. Int J Mol Sci. 2015;16(10):24011–24031. doi:10.3390/ijms16102401126473837
   PubMed Web of Science ®Google Scholar
• Panwar R, Sharma AK, Kaloti M, Dutt D, Pruthi V. Characterization and anticancer potential of ferulic acid-loaded chitosan nanoparticles against ME-180 human cervical cancer cell lines. Appl Nanosci. 2016;6(6):803–813. doi:10.1007/s13204-015-0502-y
   Web of Science ®Google Scholar
• Zhang X, Lin D, Jiang R, Li H, Wan J, Li H. Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition. Oncol Rep. 2016;36(1):271–278. doi:10.3892/or.2016.480427177074
   PubMed Web of Science ®Google Scholar
• Bairagi U, Mittal P, Singh J, Mishra B. Preparation, characterization and in-vivo evaluation of nano formulations of ferulic acid in diabetic wound healing. Drug Dev Ind Pharm. 2018;44:1783–1796. doi:10.1080/03639045.2018.1496448.
   PubMedGoogle Scholar
• Shende PK, Gaud RS, Bakal R, Patil D. Effect of inclusion complexation of meloxicam with beta-cyclodextrin- and beta-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies. Colloids Surf B Biointerfaces. 2015;136:105–110. doi:10.1016/j.colsurfb.2015.09.00226364091
   PubMed Web of Science ®Google Scholar
• Gao J, Yu H, Guo W, et al. The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells. Cancer Cell Int. 2018;18:102. doi:10.1186/s12935-018-0595-y30013454
   PubMed Web of Science ®Google Scholar
• Janicke B, Hegardt C, Krogh M, et al. The antiproliferative effect of dietary fiber phenolic compounds ferulic acid and p-coumaric acid on the cell cycle of Caco-2 cells. Nutr Cancer. 2011;63(4):611–622. doi:10.1080/01635581.2011.53848621500097
   PubMed Web of Science ®Google Scholar
• Eroglu C, Secme M, Bagci G, Dodurga Y. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines. Tumour Biol. 2015;36(12):9437–9446. doi:10.1007/s13277-015-3689-326124008
   PubMed Web of Science ®Google Scholar
• Wang T, Gong X, Jiang R, Li H, Du W, Kuang G. Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K/Akt pathway in osteosarcoma cell. Am J Transl Res. 2016;8(2):968–980.27158383
   PubMed Web of Science ®Google Scholar
• Celinska-Janowicz K, Zareba I, Lazarek U, et al. Constituents of propolis: chrysin, caffeic acid, p-coumaric acid, and ferulic acid induce PRODH/POX-dependent apoptosis in human tongue squamous cell carcinoma cell (CAL-27). Front Pharmacol. 2018;9:336. doi:10.3389/fphar.2018.0033629681859
   PubMedGoogle Scholar
• Faridi Esfanjani A, Assadpour E, Jafari SM. Improving the bioavailability of phenolic compounds by loading them within lipid-based nanocarriers. Trends Food Sci Technol. 2018;76:56–66. doi:10.1016/j.tifs.2018.04.002
   Web of Science ®Google Scholar
• Faridi Esfanjani A, Jafari SM. Biopolymer nano-particles and natural nano-carriers for nano-encapsulation of phenolic compounds. Colloids Surf B Biointerfaces. 2016;146:532–543. doi:10.1016/j.colsurfb.2016.06.05327419648
   PubMed Web of Science ®Google Scholar
• Vashisth P, Kumar N, Sharma M, Pruthi V. Biomedical applications of ferulic acid encapsulated electrospun nanofibers. Biophys Rep. 2015;8:36–44. doi:10.1016/j.btre.2015.08.008
   Google Scholar
• Aceituno-Medina M, Mendoza S, Rodríguez BA, Lagaron JM, López-Rubio A. Improved antioxidant capacity of quercetin and ferulic acid during in-vitro digestion through encapsulation within food-grade electrospun fibers. J Funct Foods. 2015;12:332–341. doi:10.1016/j.jff.2014.11.028
   Web of Science ®Google Scholar
• Poornima B, Korrapati PS. Fabrication of chitosan-polycaprolactone composite nanofibrous scaffold for simultaneous delivery of ferulic acid and resveratrol. Carbohydr Polym. 2017;157:1741–1749. doi:10.1016/j.carbpol.2016.11.05627987890
   PubMed Web of Science ®Google Scholar
• Assadpour E, Jafari SM. A systematic review on nanoencapsulation of food bioactive ingredients and nutraceuticals by various nanocarriers. Crit Rev Food Sci Nutr. 2018;1–47. doi:10.1080/10408398.2018.1484687
   PubMed Web of Science ®Google Scholar
• Gharibzahedi SMT, Jafari SM. 7 - Nanocapsule Formation by Cyclodextrins. Nanoencapsulation Technologies for the Food and Nutraceutical Industries. San Diego: Academic Press; 2017:187–261.
   Google Scholar
• Rezaei A, Nasirpour A. Encapsulation of curcumin using electrospun almond gum nanofibers: fabrication and characterization. Int J Food Prop. 2018;21(1):1608–1618. doi:10.1080/10942912.2018.1503300
   Web of Science ®Google Scholar
• Tejashri G, Amrita B, Darshana J. Cyclodextrin based nanosponges for pharmaceutical use: a review. Acta Pharm. 2013;63(3):335–358. doi:10.2478/acph-2013-002124152895
   PubMed Web of Science ®Google Scholar
• Sherje AP, Dravyakar BR, Kadam D, Jadhav M. Cyclodextrin-based nanosponges: a critical review. Carbohydr Polym. 2017;173:37–49. doi:10.1016/j.carbpol.2017.05.08628732878
   PubMed Web of Science ®Google Scholar
• Pushpalatha R, Selvamuthukumar S, Kilimozhi D. Cross-linked, cyclodextrin-based nanosponges for curcumin delivery - Physicochemical characterization, drug release, stability and cytotoxicity. J Drug Deliv Sci Technol. 2018;45:45–53. doi:10.1016/j.jddst.2018.03.004
   Web of Science ®Google Scholar
• Rezaei A, Fathi M, Jafari SM. Nanoencapsulation of hydrophobic and low-soluble food bioactive compounds within different nanocarriers. Food Hydrocoll. 2019;88:146–162. doi:10.1016/j.foodhyd.2018.10.003
   Web of Science ®Google Scholar
• Mendes C, Meirelles GC, Barp CG, Assreuy J, Silva MAS, Ponchel G. Cyclodextrin based nanosponge of norfloxacin: intestinal permeation enhancement and improved antibacterial activity. Carbohydr Polym. 2018;195:586–592. doi:10.1016/j.carbpol.2018.05.01129805015
   PubMedGoogle Scholar
• Shende P, Deshmukh K, Trotta F, Caldera F. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia. Int J Pharm. 2013;456(1):95–100. doi:10.1016/j.ijpharm.2013.08.01223954237
   PubMedGoogle Scholar
• Swaminathan S, Pastero L, Serpe L, et al. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur J Pharm Biopharm. 2010;74(2):193–201. doi:10.1016/j.ejpb.2009.11.00319900544
   PubMed Web of Science ®Google Scholar
• Maurya DK, Devasagayam TP. Antioxidant and prooxidant nature of hydroxycinnamic acid derivatives ferulic and caffeic acids. Food Chem Toxicol. 2010;48(12):3369–3373. doi:10.1016/j.fct.2010.09.00620837085
   PubMed Web of Science ®Google Scholar
• Panwar R, Raghuwanshi N, Srivastava AK, Sharma AK, Pruthi V. In-vivo sustained release of nanoencapsulated ferulic acid and its impact in induced diabetes. Mater Sci Eng C. 2018;92:381–392. doi:10.1016/j.msec.2018.06.055
   PubMed Web of Science ®Google Scholar
• Karthikeyan S, Kanimozhi G, Prasad NR, Mahalakshmi R. Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro. Toxicol In Vitro. 2011;25(7):1366–1375. doi:10.1016/j.tiv.2011.05.00721600977
   PubMed Web of Science ®Google Scholar
• Coviello V, Sartini S, Quattrini L, Baraldi C, Gamberini MC, La Motta C. Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: a novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention. Eur J Pharm Biopharm. 2017;117:276–285. doi:10.1016/j.ejpb.2017.04.02828456606
   PubMedGoogle Scholar
• Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech. 2011;12(1):279–286. doi:10.1208/s12249-011-9584-321240574
   PubMed Web of Science ®Google Scholar
• Dora CP, Trotta F, Kushwah V, et al. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability. Carbohydr Polym. 2016;137:339–349. doi:10.1016/j.carbpol.2015.10.08026686138
   PubMed Web of Science ®Google Scholar
• Galati G, O’Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med. 2004;37(3):287–303. doi:10.1016/j.freeradbiomed.2004.04.03415223063
   PubMed Web of Science ®Google Scholar
• Ezhuthupurakkal PB, Ariraman S, Arumugam S, et al. Anticancer potential of ZnO nanoparticle-ferulic acid conjugate on Huh-7 and HepG2 cells and diethyl nitrosamine induced hepatocellular cancer on Wistar albino rat. Nanomedicine. 2018;14(2):415–428. doi:10.1016/j.nano.2017.11.00329166623
   PubMed Web of Science ®Google Scholar